HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheng-Chia Yu Selected Research

Oral Submucous Fibrosis

6/2022Down-regulation of miR-29c promotes the progression of oral submucous fibrosis through targeting tropomyosin-1.
4/2022The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis.
2/2022Depletion of miR-155 hinders the myofibroblast activities and reactive oxygen species generation in oral submucous fibrosis.
5/2021Inhibition of lncRNA HOTTIP ameliorated myofibroblast activities and inflammatory cytokines in oral submucous fibrosis.
2/2021Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis.
4/2020Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
3/2019Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition.
8/2018LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis.
6/2018Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosis.
4/2018Hinokitiol ablates myofibroblast activation in precancerous oral submucous fibrosis by targeting Snail.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheng-Chia Yu Research Topics

Disease

54Neoplasms (Cancer)
10/2022 - 07/2008
21Squamous Cell Carcinoma of Head and Neck
10/2022 - 10/2010
21Mouth Neoplasms (Oral Cancer)
05/2022 - 09/2011
14Fibrosis (Cirrhosis)
05/2022 - 03/2016
13Neoplasm Metastasis (Metastasis)
10/2022 - 01/2010
13Oral Submucous Fibrosis
06/2022 - 01/2013
12Carcinoma (Carcinomatosis)
10/2022 - 01/2017
10Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 10/2010
9Carcinogenesis
04/2022 - 02/2013
8Gingival Overgrowth
06/2021 - 01/2015
8Tics (Tic)
06/2020 - 03/2012
3Periodontal Diseases (Periodontal Disease)
04/2022 - 06/2021
3Inflammation (Inflammations)
07/2021 - 12/2014
3Infections
06/2020 - 01/2013
2Precancerous Conditions
06/2022 - 05/2021
2Periodontitis
07/2021 - 06/2021
2Hypoxia (Hypoxemia)
04/2020 - 01/2015
2Lung Neoplasms (Lung Cancer)
08/2017 - 04/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2014 - 01/2010
2Breast Neoplasms (Breast Cancer)
02/2013 - 11/2011
1Esophageal Neoplasms (Esophageal Cancer)
01/2021
1Ascites
01/2020
1Oral Lichen Planus
04/2018
1Glioma (Gliomas)
08/2017

Drug/Important Bio-Agent (IBA)

16MicroRNAs (MicroRNA)IBA
06/2022 - 01/2010
11Proteins (Proteins, Gene)FDA Link
11/2021 - 11/2011
11Long Noncoding RNAIBA
05/2021 - 07/2016
7Arecoline (Arecolin)IBA
02/2021 - 01/2013
7Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2020 - 01/2015
6Pharmaceutical PreparationsIBA
10/2022 - 08/2014
6Messenger RNA (mRNA)IBA
10/2020 - 01/2012
6Cisplatin (Platino)FDA LinkGeneric
11/2018 - 09/2011
5Transcription Factors (Transcription Factor)IBA
10/2022 - 01/2013
5Therapeutic UsesIBA
08/2014 - 03/2012
4Biomarkers (Surrogate Marker)IBA
04/2022 - 11/2011
4Biological ProductsIBA
06/2021 - 01/2011
4CollagenIBA
05/2021 - 01/2013
4Immunosuppressive Agents (Immunosuppressants)IBA
12/2018 - 12/2015
33' Untranslated Regions (3' UTR)IBA
04/2022 - 03/2011
3Untranslated RNA (Noncoding RNA)IBA
04/2022 - 07/2019
3LuciferasesIBA
04/2022 - 03/2011
3Collagen Type I (Type I Collagen)IBA
11/2021 - 07/2019
3Small Interfering RNA (siRNA)IBA
08/2020 - 05/2012
3Interleukin-6 (Interleukin 6)IBA
06/2020 - 06/2013
3beta-thujaplicinIBA
04/2018 - 06/2013
3BerberineIBA
01/2018 - 12/2014
3NestinIBA
07/2017 - 07/2008
3ResveratrolIBA
03/2016 - 03/2012
2LipidsIBA
10/2022 - 01/2020
2butylidenephthalideIBA
05/2022 - 06/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 01/2013
2magnololIBA
01/2022 - 07/2021
2Fibronectins (Fibronectin)IBA
11/2021 - 04/2020
2honokiolIBA
11/2021 - 11/2018
2CytokinesIBA
05/2021 - 06/2013
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2020 - 02/2020
2RNA (Ribonucleic Acid)IBA
04/2020 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2012
2AcidsIBA
08/2018 - 01/2014
21-phenyl-3,3-dimethyltriazene (PDT)IBA
08/2018 - 01/2014
2isoliquiritigenin (GU 17)IBA
11/2017 - 01/2016
2Endoplasmic Reticulum Chaperone BiPIBA
11/2017 - 10/2010
2FlavonoidsIBA
11/2017 - 03/2016
2PhytochemicalsIBA
08/2017 - 01/2014
2Plasminogen Activators (Plasminogen Activator)IBA
01/2016 - 01/2015
2Plasminogen Activator Inhibitor 1IBA
01/2016 - 01/2015
2Polyurethanes (Polyurethane)IBA
05/2012 - 04/2012
1Fenofibrate (CiL)FDA LinkGeneric
10/2022
1Aldehyde Dehydrogenase 1 FamilyIBA
05/2022
1paeonolIBA
05/2022
1Photosensitizing Agents (Photosensitizers)IBA
04/2022
1temoporfinIBA
04/2022
1NucleotidesIBA
04/2022
1PeriostinIBA
11/2021
1mouse MIRN29 microRNAIBA
02/2021
1Protein Glutamine gamma Glutamyltransferase 2IBA
10/2020
1IsoflavonesIBA
06/2020
1Phytoestrogens (Phytoestrogen)IBA
06/2020
1GenisteinIBA
06/2020
1UbiquitinIBA
02/2020
1Tumor Biomarkers (Tumor Markers)IBA
01/2020
1LignansIBA
03/2019
1arctigeninIBA
03/2019
1Interleukin-8 (Interleukin 8)IBA
07/2018
1phthalideIBA
06/2018
1TropoloneIBA
04/2018
1glabridinIBA
02/2018
1Antisense RNA (Anti-Sense RNA)IBA
11/2017
1Chalcone (Benzalacetophenone)IBA
11/2017
1Adenosine Triphosphate (ATP)IBA
07/2017
1Methotrexate (Mexate)FDA LinkGeneric
07/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2017

Therapy/Procedure

19Therapeutics
05/2022 - 01/2012
4Heterologous Transplantation (Xenotransplantation)
11/2017 - 10/2010
3Photochemotherapy (Photodynamic Therapy)
04/2022 - 01/2014
3Drug Therapy (Chemotherapy)
11/2017 - 08/2012
3Radiotherapy
07/2016 - 03/2012
1Oral Hygiene (Dental Hygiene)
08/2020
1Precision Medicine
02/2020
1Oral Administration
09/2017